130 related articles for article (PubMed ID: 6839760)
21. Prolactin-secreting pituitary adenomas. III. Frequency and diagnosis in amenorrhea-galactorrhea.
Keye WR; Chang RJ; Wilson CB; Jaffe RB
JAMA; 1980 Sep; 244(12):1329-32. PubMed ID: 7191013
[TBL] [Abstract][Full Text] [Related]
22. [Amenorrhoea following oral contraception. Pathophysiological problems (author's transl)].
Schaison G
Nouv Presse Med; 1980 Nov; 9(41):3083-6. PubMed ID: 7443448
[TBL] [Abstract][Full Text] [Related]
23. Contraceptive choices for women with endocrine complications.
Loriaux DL; Wild RA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):2021-6. PubMed ID: 8512047
[TBL] [Abstract][Full Text] [Related]
24. [Post-pill amenorrhea and prolactin].
Volpe A; Baviera G; Montanari GD
Riv Ital Ginecol; 1977; 58(4):247-52. PubMed ID: 756597
[TBL] [Abstract][Full Text] [Related]
25. Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Lazarus L
J Clin Endocrinol Metab; 1983 Apr; 56(4):692-6. PubMed ID: 6833458
[No Abstract] [Full Text] [Related]
26. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
27. [Amenorrhea and the pill].
Verdino P; Viard R; Harter M
Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives.
Klein TA; Mishell DR
Am J Obstet Gynecol; 1977 Mar; 127(6):585-9. PubMed ID: 842583
[TBL] [Abstract][Full Text] [Related]
29. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
Ryu K; Hong SS
Contraception; 1983 Jun; 27(6):605-17. PubMed ID: 6413131
[TBL] [Abstract][Full Text] [Related]
30. [Fertility and characteristics of ovulation after discontinuing oral contraception].
Gaspard U; Lambotte R
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
[TBL] [Abstract][Full Text] [Related]
31. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
Balogh A; Ditrói F; Lampé LG
Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
[TBL] [Abstract][Full Text] [Related]
32. Discordant patterns of hyperprolactinaemia and galactorrhoea in secondary amenorrhoea.
Seppälä M; Lehtovirta P; Ranta T
Acta Endocrinol (Copenh); 1977 Nov; 86(3):457-63. PubMed ID: 579018
[TBL] [Abstract][Full Text] [Related]
33. Contraceptive steroid effects on nonreproductive organ systems.
Corson SL
J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
35. Blood prolactin levels: influence of age, menstrual cycle and oral contraceptives.
Pansini F; Bianchi A; Zito V; Mollica G; Cavallini AR; Candini GC; Bagni B; Bergamini C; Bassi P
Contraception; 1983 Sep; 28(3):201-7. PubMed ID: 6641222
[TBL] [Abstract][Full Text] [Related]
36. The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions.
Silber M; Almkvist O; Larsson B; Stock S; Uvnäs-Moberg K
Contraception; 1987 Dec; 36(6):641-50. PubMed ID: 3128427
[TBL] [Abstract][Full Text] [Related]
37. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.
Kleinberg DL; Noel GL; Frantz AG
N Engl J Med; 1977 Mar; 296(11):589-600. PubMed ID: 840242
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of prolactin-secreting pituitary adenomas.
Sherman BM; Harris CE; Schlechte J; Duello TM; Halmi NS; VanGilder J; Chapler FK; Granner DK
Lancet; 1978 Nov; 2(8098):1019-21. PubMed ID: 82034
[TBL] [Abstract][Full Text] [Related]
39. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
Carlborg L
Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
